|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
School of Biological Sciences, University of East Anglia, Norwich, NR4
7TJ, UK
* Present address: St. Vincent's Institute of Medical Research, 9 Princes
Street, Fitzroy, Victoria 3065, Australia
Author for correspondence (e-mail:
dylan.edwards{at}uea.ac.uk)
Accepted 10 June 2002
Macro- and microvascular endothelial cells (EC) formed tubular structures when cultured within a 3D fibrin matrix, a process that was enhanced by vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), hepatocyte growth factor/scatter factor (HGF/SF) and an angiogenic cocktail composed of nine angiogenic factors. Endothelial tubulogenesis was also increased in co-culture with tumour cells such as U87 glioma cells, but not with non-tumorigenic cell types such as Madin-Darby canine kidney (MDCK) epithelial cells. VEGF/FGF-2-stimulated tube formation was dependent on metalloproteinase function [it is inhibited by the addition of tissue inhibitor of metalloproteinases-2 (TIMP-2)], whereas aprotinin, E64 [trans-epoxysuccinyl-L-leucylamido (4-guanidino)-butane] and pepstatin had no effect. In addition, TIMP-4 also inhibited tubulogenesis, but TIMP-1 or the C-terminal haemopexin domain of matrix metalloproteinase-2 (MMP-2) (PEX) and an anti-MMP-2 function-blocking antibody were unable to block tube formation. This suggests that MMP-2 and other soluble MMPs are not essential for tubulogenesis in fibrin gels, instead TIMP-1-insensitive MMPs, such as members of the membrane type-MMPs (MT-MMP) sub-group (MT1-, MT2-, MT3- or MT5-MMP), are required for this process. Further support for a role for MT1-MMP in endothelial tubulogenesis is that recombinant Y36G N-terminal TIMP-2 mutant protein, which retains an essentially unaltered apparent inhibition constant (Kiapp) for several MMPs compared to wild-type N-TIMP-2 but is a 40-fold poorer inhibitor of MT1-MMP, was unable to block tubulogenesis. Furthermore, when EC were cultured within fibrin gels, the mRNA levels of several MMPs (including MT1-MMP, MT2-MMP, MT3-MMP and MMP-2) increased during tubulogenesis. Therefore MT-MMPs and specifically MT1-MMP are likely candidates for involvement during endothelial tubulogenesis within a fibrin matrix, and thus their blockade may be a viable strategy for inhibition of angiogenesis.
Key words: MT-MMPs, Fibrin gels, Tubulogenesis, Endothelial, Angiogenesis
Related articles in JCS:
This article has been cited by other articles:
|
|
 |
|
  H. Kang, K. J. Bayless, and R. Kaunas Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2087 - H2097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Hirschi, D. A. Ingram, and M. C. Yoder Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1584 - 1595. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chetty, S. S. Lakka, P. Bhoopathi, S. Kunigal, R. Geiss, and J. S. Rao Tissue Inhibitor of Metalloproteinase 3 Suppresses Tumor Angiogenesis in Matrix Metalloproteinase 2-Down-regulated Lung Cancer Cancer Res., June 15, 2008; 68(12): 4736 - 4745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lipton, K. Leitzel, H. A. Chaudri-Ross, D. B. Evans, S. M. Ali, L. Demers, P. Hamer, S. Brown-Shimer, K. Pierce, V. Gaur, et al. Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer J. Clin. Oncol., June 1, 2008; 26(16): 2653 - 2658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Plaisier, P. Koolwijk, F. Willems, F. M. Helmerhorst, and V. W.M. van Hinsbergh Pericellular-acting proteases in human first trimester decidua Mol. Hum. Reprod., January 1, 2008; 14(1): 41 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Guttmann-Raviv, N. Shraga-Heled, A. Varshavsky, C. Guimaraes-Sternberg, O. Kessler, and G. Neufeld Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis J. Biol. Chem., September 7, 2007; 282(36): 26294 - 26305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Hodgkinson, G. Duncan, L. Wang, C. J. Pennington, D. R. Edwards, and I. M. Wormstone MMP and TIMP Expression in Quiescent, Dividing, and Differentiating Human Lens Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Yana, H. Sagara, S. Takaki, K. Takatsu, K. Nakamura, K. Nakao, M. Katsuki, S.-i. Taniguchi, T. Aoki, H. Sato, et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells J. Cell Sci., May 1, 2007; 120(9): 1607 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ramont, S. Brassart-Pasco, J. Thevenard, A. Deshorgue, L. Venteo, J. Y. Laronze, M. Pluot, J.-C. Monboisse, and F.-X. Maquart The NC1 domain of type XIX collagen inhibits in vivo melanoma growth Mol. Cancer Ther., February 1, 2007; 6(2): 506 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Saunders, B. L. Bohnsack, J. B. Faske, N. J. Anthis, K. J. Bayless, K. K. Hirschi, and G. E. Davis Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3 J. Cell Biol., October 9, 2006; 175(1): 179 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Morrison and C. M. Overall TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains J. Biol. Chem., September 8, 2006; 281(36): 26528 - 26539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lamy, M. Blanchette, J. Michaud-Levesque, R. Lafleur, Y. Durocher, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation Carcinogenesis, May 1, 2006; 27(5): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Plaisier, P. Koolwijk, R. Hanemaaijer, R. A. Verwey, R. M.F. van der Weiden, E. K.J. Risse, C. Jungerius, F. M. Helmerhorst, and V. W.M. van Hinsbergh Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle Mol. Hum. Reprod., January 1, 2006; 12(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, S. Sarkar, and V.W. Yong The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase Carcinogenesis, December 1, 2005; 26(12): 2069 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ben-Yosef, A. Miller, S. Shapiro, and N. Lahat Hypoxia of endothelial cells leads to MMP-2-dependent survival and death Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1321 - C1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. E. Helm, M. E. Fleury, A. H. Zisch, F. Boschetti, and M. A. Swartz Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism PNAS, November 1, 2005; 102(44): 15779 - 15784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Nisato, G. Hosseini, C. Sirrenberg, G. S. Butler, T. Crabbe, A. J.P. Docherty, M. Wiesner, G. Murphy, C. M. Overall, S. L. Goodman, et al. Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin {alpha}v{beta}3 in Angiogenesis In vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and {alpha}v{beta}3 Are Critical Cancer Res., October 15, 2005; 65(20): 9377 - 9387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Abounader and J. Laterra Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis Neuro-oncol, October 1, 2005; 7(4): 436 - 451. [Abstract] [PDF]
|
|
|
|
|
|
K. A. Mace, S. L. Hansen, C. Myers, D. M. Young, and N. Boudreau HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair J. Cell Sci., June 15, 2005; 118(12): 2567 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. O. Wurtz, I. J. Christensen, A.-S. Schrohl, H. Mouridsen, U. Lademann, V. Jensen, and N. Brunner Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients Mol. Cell. Proteomics, April 1, 2005; 4(4): 483 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cao, A. Hong, H. Schulten, and M. J. Post Update on therapeutic neovascularization Cardiovasc Res, February 15, 2005; 65(3): 639 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Robinet, A. Fahem, J.-H. Cauchard, E. Huet, L. Vincent, S. Lorimier, F. Antonicelli, C. Soria, M. Crepin, W. Hornebeck, et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP J. Cell Sci., January 15, 2005; 118(2): 343 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Chun, F. Sabeh, I. Ota, H. Murphy, K. T. McDonagh, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, and S. J. Weiss MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix J. Cell Biol., November 22, 2004; 167(4): 757 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Plaisier, K. Kapiteijn, P. Koolwijk, C. Fijten, R. Hanemaaijer, J. M. Grimbergen, A. Mulder-Stapel, P. H. A. Quax, F. M. Helmerhorst, and V. W. M. van Hinsbergh Involvement of Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Capillary Tube Formation by Human Endometrial Microvascular Endothelial Cells: Role of MT3-MMP J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5828 - 5836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bein, E. T. Odell-Fiddler, and M. Drinane Role of TGF-{beta}1 and JNK signaling in capillary tube patterning Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1012 - C1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Langlois, D. Gingras, and R. Beliveau Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation Blood, April 15, 2004; 103(8): 3020 - 3028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Sounni, C. Roghi, V. Chabottaux, M. Janssen, C. Munaut, E. Maquoi, B. G. Galvez, C. Gilles, F. Frankenne, G. Murphy, et al. Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases J. Biol. Chem., April 2, 2004; 279(14): 13564 - 13574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-S. Schrohl, M. N. Holten-Andersen, H. A. Peters, M. P. Look, M. E. Meijer-van Gelder, J. G. M. Klijn, N. Brunner, and J. A. Foekens Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer Clin. Cancer Res., April 1, 2004; 10(7): 2289 - 2298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Hess, E. A. Seftor, R. E. B. Seftor, and M. J. C. Hendrix Phosphoinositide 3-Kinase Regulates Membrane Type 1-Matrix Metalloproteinase (MMP) and MMP-2 Activity during Melanoma Cell Vasculogenic Mimicry Cancer Res., August 15, 2003; 63(16): 4757 - 4762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Nuttall, C. J. Pennington, J. Taplin, A. Wheal, V. W. Yong, P. A. Forsyth, and D. R. Edwards Elevated Membrane-Type Matrix Metalloproteinases in Gliomas Revealed by Profiling Proteases and Inhibitors in Human Cancer Cells Mol. Cancer Res., March 1, 2003; 1(5): 333 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-S. Schrohl, I. J. Christensen, A. N. Pedersen, V. Jensen, H. Mouridsen, G. Murphy, J. A. Foekens, N. Brunner, and M. N. Holten-Andersen Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer Mol. Cell. Proteomics, March 1, 2003; 2(3): 164 - 172. [Abstract] [Full Text] [PDF]
|
|
